Metabotropic glutamate receptor 7: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
Line 23: Line 23:
{{Neuroscience-stub}}
{{Neuroscience-stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 19:22, 17 March 2025

Metabotropic glutamate receptor 7 (mGluR7) is a type of metabotropic glutamate receptor which is a part of the G protein-coupled receptor family. These receptors are found in the central nervous system and play a crucial role in neurotransmission.

Function[edit]

mGluR7 is involved in the regulation of synaptic transmission and neuronal excitability. It is predominantly expressed in the presynaptic terminal and is activated by the neurotransmitter glutamate. Upon activation, mGluR7 inhibits the release of glutamate and other neurotransmitters, thereby modulating synaptic transmission.

Structure[edit]

Like other metabotropic glutamate receptors, mGluR7 is a G protein-coupled receptor that consists of seven transmembrane domains. It is coupled to the inhibitory G protein (Gi/o), which inhibits the activity of adenylyl cyclase and reduces the production of cyclic AMP.

Clinical significance[edit]

Alterations in the function or expression of mGluR7 have been implicated in several neurological and psychiatric disorders, including anxiety, depression, schizophrenia, and epilepsy. Therefore, mGluR7 is considered a potential therapeutic target for these disorders.

Research[edit]

Research on mGluR7 has been focused on understanding its role in the pathophysiology of various disorders and developing drugs that can modulate its activity. Several mGluR7 agonists and antagonists have been identified and are being studied for their potential therapeutic effects.

See also[edit]

Stub icon
   This article is a neuroscience stub. You can help WikiMD by expanding it!